Advancements in cardiac care and novel therapies are transforming cardiac medical devices, providing new solutions for millions affected by heart disease globally.
Up until now, the lack of interoperable health-at-home devices has inhibited health technology integration into the home for use in wellness, prevention, managing chronic conditions, and clinical trials.
careviso Survey Highlights Major Communication Gaps in Healthcare, Impacting Financial Transparency and Patient Experience
Health IT interoperability advocacy group, The Sequoia Project released its latest Data Usability Implementation Guide including added guidance for receiving systems, advanced baseline requirements from USCDI V1, and more.
The integration of technology and connectivity into healthcare is not only improving patient outcomes but also reshaping the way care is delivered.
The AI Training Dataset Market size is projected CAGR of 27.7% in the coming years. By 2024, the market had reached an approximate value of USD 2.82 billion and is forecasted to reach USD 9.58 billion by 2029, according to a new report by MarketsandMarkets™.
Could MedTech find itself as the collateral damage if an RFK Jr. run HHS “goes wild” with FDA regulation of pharma and processed foods?
The MDIC Annual Public Forum 2024 kicked off this week with experts from the National Evaluation System for health Technology (NEST), the Centers for Medicare and Medicaid Services (CMS), and the FDA. Topics included the future of real-world evidence (RWE) and the integration of AI into the healthcare ecosystem and how can we leverage emerging technologies to bring innovative and safer solutions to patients.
In the light of new research, Peter Muller and Mike Baird of Schlafender Hase assess how well Class 2 and 3 device manufacturers in Europe and the US are adapting to a rise in regulatory controls.
Congress must decide the future of the Acute Hospital Care at Home (AHCAH) program, an initiative of the Centers for Medicare & Medicaid Services (CMS) that, without legislative action, will expire on December 31, 2024. To ensure beneficiaries can receive various levels of care in their preferred settings, this brief provides immediate–term federal policy reform recommendations for the potential reauthorization of the AHCAH model while outlining key issues for policymakers to consider when further research and data emerge.
